GCB News

Svati Shah Named Director of Duke Precision Genomics Collaboratory

Svati Shah, M.D., MHS, has been appointed director of the Duke Precision Genomics Collaboratory and associate dean of genomics.

The Genomic Medicine Collaboratory will spur innovations in precision medicine, genetics and genomics to achieve distinguished impacts in genetics-based discoveries, research methods and translational care to clinical care. Several members of the Duke Center for Genomic and Computational Biology (GCB) will take part in this collaboratory.

GCB Receives Grant To Create New International Training Program

The Center for Genomic and Computational Biology (GCB) received a grant from the National Science Foundation (NSF) to create an International Research Experiences for Students (IRES) program called “Dissecting the Regulatory Genome Duke-Berlin Training Program.”

Bruce Donald's company featured at Duke Venture Day

Bruce Donald’s company, Gavilán Biodesign, was featured as one of eight Duke start-up investments at the first Duke Venture Day earlier this month. This event showcased therapeutic innovations currently coming out of Duke. Gavilan Biodesign was recently selected as one of 11 early-stage biotech companies at the Silicon Valley biotech accelerator, IndieBio. Their technology combines state of the art physics-based modeling with a unique high accuracy AI platform to computationally screen trillions of molecules in order to find therapeutics that can overcome resistance. 

Marchuk awarded Research Mentoring Award for Basic Science

Doug Marchuk, Ph.D., Duke Professor of Molecular Genetics and Microbiology, was recognized at the 2019 Spring Faculty Meeting and awarded a Research Mentoring Award for Basic Science. The Research Mentoring Awards recognize faculty members of the Schools of Medicine and Nursing with excellence in research monitoring. 

Research Roundup: April 2019

Here are summaries of a selection of the papers published by GCB faculty in April 2019:

NEW METHODS

Andrew Allen was part of a team that developed two new methods that pinpoint risk regions of amyotrophic lateral sclerosis (ALS) genes. These new methods not only pinpoint risk regions in known genes, but also highlight candidate genes as well. Read more

GCB gears up for new summer recruits through the Summer Scholars program

GCB has teamed up with the Duke Center for Applied Genomics and Precision Medicine (CAGPM) and North Carolina Central University (NCCU) for the second annual Summer Scholars Program in Genome Sciences and Medicine, supported by the National Human Genome Research Institute at NIH. This 10-week program is designed for full-time first- and second-year underrepresented minority (URM) students at any college or university.

Guts and Glory: David Lab Studies Gut Microbiome

Like fingerprints, everyone has a unique gut microbiome. The gut microbiome, the largest population of microbes in the body, affects a person from birth throughout life by impacting the immune system, central nervous system, digestion and other bodily processes.

Lawrence David and his lab are conducting a study to examine how prebiotic fiber supplements affect the gut microbiome. They will be analyzing participants’ diet, microbiota and metabolism.